Amanote Research
Register
Sign In
Pcn250 - Assessing the Real World Usage of Pd-1 Inhibitors in Advanced Melanoma Across Eu5
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.332
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
A. Rider
K. Lewis
O. Higson
Publisher
Elsevier BV
Related search
Real-World Evidenceand Clinical Observations of the Treatment of Advanced Non-Small Cell Lung Cancer With PD-1/PD-L1 Inhibitors
Scientific Reports
Multidisciplinary
22PIpilimumab for Advanced Melanoma in the Real World: The Northern Ireland Experience
Annals of Oncology
Medicine
Oncology
Hematology
Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma
BMC Cancer
Cancer Research
Oncology
Genetics
Factors Influencing the Efficacy of Anti-Pd-1 Therapy in Chinese Patients With Advanced Melanoma
Journal of Oncology
Oncology
Pcn332 - Real-World Usage of Bortezomib in Combination With Thalidomide and Dexamethasone (Vtd) as Frontline (Fl) Treatment in Stem Cell Transplant (Sct) Eligible Multiple Myeloma (Mm) Patients Across Eu5 Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
777 Enhanced Recovery of PD-1 Expression on the Cell Surface of PD-1 Negative T Cells in Nivolumab-Treated Advanced Melanoma Patients
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Pcn340 - Real-World Usage of Bortezomib in Combination With Melphalan and Prednisone (Vmp) as Frontline (Fl) Treatment in Stem Cell Transplant (Sct) Ineligible Multiple Myeloma (Mm) Patients Across Eu5 Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php245 - Understanding the Impact of Real World Evidence on Reimbursement Decisions Across Eu5 Countries Using a Web-Based Portal to Engage Payers
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Beyond PD-1 Immunotherapy in Malignant Melanoma
Dermatology and Therapy
Dermatology
